Joseph Park

Executive Director, Medical Affairs at Prelude Therapeutics - Wilmington, Delaware, US

Joseph Park's Contact Details
HQ
(302) 467-1280
Location
New York City Metropolitan Area
Company
Prelude Therapeutics
Joseph Park's Company Details
Prelude Therapeutics logo, Prelude Therapeutics contact details

Prelude Therapeutics

Wilmington, Delaware, US • 151 Employees
BioTech/Drugs

Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company’s diverse pipeline is comprised of highly differentiated, potentially best-in-class proprietary small molecule compounds aimed at addressing clinically validated pathways forcancers with selectable underserved patients. Prelude’s pipeline includes three candidates currently in clinical development: PRT3789 an IV administered, potent and highly selective SMARCA2 degrader, PRT2527, a potent and highly selective CDK9 inhibitor, PRT3645 a next generation CDK4/6 inhibitor, and a preclinical oral candidate targeting SMARCA2.

Precision Oncology Oncology Cancer Treatment
Details about Prelude Therapeutics
Frequently Asked Questions about Joseph Park
Joseph Park currently works for Prelude Therapeutics.
Joseph Park's role at Prelude Therapeutics is Executive Director, Medical Affairs.
Joseph Park's email address is ***@preludetx.com. To view Joseph Park's full email address, please signup to ConnectPlex.
Joseph Park works in the BioTech/Drugs industry.
Joseph Park's colleagues at Prelude Therapeutics are Alan Morton, Robert Landman, Ashish Juvekar, William Gowen-MacDonald, Philip Pitis, Brittany Teal, David Mauro and others.
Joseph Park's phone number is (302) 467-1280
See more information about Joseph Park